Traci Desplinter, MD
Obstetrics & Gynecology · Houston, TXNPI 1912956012
Payments from drug & device makers
Across 139 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$602
- AbbVie$254
- Sumitomo Pharma America, Inc.$203
- Johnson & Johnson$195
- Evofem Biosciences, Inc.$158
- Medtronic$140
- plus $2K from 35 others
What the payments were for
- Food & beverage$3,09299%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 30 | $602 |
| AbbVie(2 entities) | 13 | $254 |
| Sumitomo Pharma America, Inc. | 9 | $203 |
| Johnson & Johnson | 4 | $195 |
| Evofem Biosciences, Inc. | 9 | $158 |
| Medtronic | 3 | $140 |
| Mayne Pharma Commercial LLC | 5 | $135 |
| Bayer | 5 | $112 |
| Convatec Inc. | 2 | $104 |
| Tempus AI, Inc | 1 | $98 |
| Hologic Sales And Service, LLC | 5 | $94 |
| Pfizer | 6 | $82 |
| Myovant Sciences Inc. | 4 | $78 |
| Roche Diagnostics Corporation | 3 | $56 |
| Biogen | 2 | $54 |
| Allotrope Medical, Inc | 1 | $54 |
| Coopersurgical, Inc. | 3 | $51 |
| Meditrina | 3 | $45 |
| Smith+Nephew | 2 | $41 |
| Baxter Healthcare | 1 | $41 |
| Octapharma USA, Inc. | 1 | $40 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Avion Pharmaceuticals | 2 | $37 |
| Avanos Medical | 1 | $35 |
| Medicem Inc. | 2 | $31 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Exeltis, USA Inc. | 2 | $30 |
| Agile Therapeutics, Inc. | 2 | $29 |
| Duchesnay USA Incorporated | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $23 |
| Minerva Surgical, Inc | 2 | $23 |
| Axonics, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Dilon Technologies, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Organon | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| Renovia Inc | 1 | $16 |
| Acessa Health Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,123 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $782 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Mark JacobsHouston$2.8M
- Sandra HurtadoHouston$1.7M
- Dawn BlackHouston$1.2M
- George KuhnHouston$244K
- Luis Sandoval-MartinezHouston$234K
- Daisy AyimHouston$188K
- Asha BhalwalHouston$151K
- Monica LopezFort Worth$8.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.